What lymph node stations are recommended for dissection in a radical cholecystectomy (surgical removal of the gallbladder)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lymph Node Stations in Radical Cholecystectomy for Gallbladder Cancer

For radical cholecystectomy in gallbladder cancer, you must dissect three mandatory regional lymph node stations: porta hepatis (station 12), gastrohepatic ligament, and retroduodenal (station 13) nodes. 1

Mandatory Regional Lymph Node Stations

The standard regional lymphadenectomy must include:

  • Station 12 (porta hepatis): This includes stations 12a, 12b, 12c, and 12p (posterior), with metastasis rates up to 41.5% in this station 1, 2
  • Gastrohepatic ligament nodes: Including lymph nodes along the lesser curvature 1
  • Station 13 (retroduodenal/retropancreatic): These nodes posterior to the duodenum and pancreatic head must be dissected 1, 2

Additional regional stations that should be included:

  • Cystic duct lymph node 2
  • Common bile duct lymph node 2
  • Hepatic artery and portal vein lymph nodes within the hepatoduodenal ligament 2

Stations Indicating Unresectable Disease

Do not attempt curative resection if nodal disease extends beyond regional stations, as this represents distant metastatic disease:

  • Station 9 (celiac axis): Metastasis here carries a 28% rate and 0% 5-year survival 1
  • Retropancreatic nodes beyond station 13 1
  • Interaortocaval groove nodes (station 16): These should be sampled for staging but their involvement indicates unresectable disease 1, 3
  • Para-aortic nodes: Extended dissection to these stations increases morbidity without survival benefit 1

Stage-Specific Lymphadenectomy Requirements

The extent of lymphadenectomy depends on tumor stage:

  • T1a tumors: Simple cholecystectomy alone is adequate; lymphadenectomy provides no survival benefit due to 0% metastasis rate 1
  • T1b tumors or greater: Regional lymphadenectomy is mandatory, with metastasis rates of 61.9% for T2 and 81.3% for T3/T4 disease 1
  • T2 or higher: Extended cholecystectomy with complete regional lymphadenectomy is the standard of care 2, 4

Minimum Lymph Node Evaluation

Pathologic evaluation of at least one lymph node is critical for survival benefit—radical resection without lymph node evaluation provides no survival advantage over simple cholecystectomy alone 5. For T1B and T2 tumors, radical resection with lymph node evaluation yields median overall survival of 123 months versus 22 months without nodal evaluation 5.

Technical Approach Considerations

A lateral laparoscopic approach provides superior visualization of the dorsal hepatoduodenal ligament structures, facilitating complete dissection of retro-portal and retropancreatic lymph nodes (stations 12p and 13) 6, 3. This approach allows 360-degree exposure of the portal vein and safer dissection of posterior structures 6.

Critical Pitfalls to Avoid

  • Never perform extended lymphadenectomy beyond regional stations (celiac, para-aortic) as routine practice—this increases morbidity without survival benefit and indicates unresectable disease 1
  • Do not proceed with radical resection if you cannot evaluate lymph nodes—radical resection without nodal evaluation offers no benefit over simple cholecystectomy 5
  • Avoid incomplete portal lymphadenectomy—all subsections of station 12 (a, b, c, p) must be dissected for adequate staging 2, 3
  • Extended resection with pancreaticoduodenectomy should only be considered for selected cases with evident peripancreatic nodal disease and should be limited to expert hepatobiliary surgeons due to significant morbidity 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.